AI Verdict
MRK has stronger fundamentals based on our AI analysis.
ABBV vs MRK Fundamental Comparison
| Metric | ABBV | MRK |
|---|---|---|
| Revenue | $15.0B | $16.3B |
| Net Income | $695.0M | $-4.2B |
| Net Margin | 4.6% | -26.0% |
| ROE | N/A | -9.2% |
| ROA | 0.5% | -3.3% |
| Current Ratio | 0.80x | 1.30x |
| Debt/Equity | N/A | 1.02x |
| EPS | $0.39 | $-1.72 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs MRK: Frequently Asked Questions
Is ABBV or MRK the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MRK has stronger fundamentals. ABBV is graded C (78% confidence) while MRK is graded B (78% confidence). This is not investment advice.
How does ABBV compare to MRK fundamentally?
AbbVie Inc. has ROE of N/A vs Merck & Co., Inc.'s -9.2%. Net margins are 4.6% vs -26.0% respectively.
Which stock pays higher dividends, ABBV or MRK?
ABBV has a dividend yield of N/A or no dividend while MRK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or MRK for long term?
For long-term investing, consider that ABBV has a C grade with 78% confidence, while MRK has a B grade with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs MRK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs MRK, the AI consensus favors MRK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.